However, although the favorable outcome of BCP-ALL withERG deletions seems to derive from that of theDUX4r-ALL subtype, the outcome ofDUX4r-ALL and potential prognostic impact ofERG deletions within this subgroup should be further studied in larger and uniformly treated cohorts of patients. This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.